FDA NDC Directory · JSON-LD · Markdown

XOLAIR

NDC 50242-040 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameomalizumab
Labeler / ManufacturerGenentech, Inc.
Marketing categoryBiologic License Application · App BLA103976
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsOMALIZUMAB (150 mg/1.2mL)
Marketing started20030620
Package count2

External sources

Source: openFDA. Public-domain (CC0).